Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

616 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Improved survival with bisoprolol in patients with heart failure and renal impairment: an analysis of the cardiac insufficiency bisoprolol study II (CIBIS-II) trial.
Castagno D, Jhund PS, McMurray JJ, Lewsey JD, Erdmann E, Zannad F, Remme WJ, Lopez-Sendon JL, Lechat P, Follath F, Höglund C, Mareev V, Sadowski Z, Seabra-Gomes RJ, Dargie HJ. Castagno D, et al. Among authors: lechat p. Eur J Heart Fail. 2010 Jun;12(6):607-16. doi: 10.1093/eurjhf/hfq038. Epub 2010 Mar 30. Eur J Heart Fail. 2010. PMID: 20354032 Free article. Clinical Trial.
Comparison of treatment initiation with bisoprolol vs. enalapril in chronic heart failure patients: rationale and design of CIBIS-III.
Willenheimer R, Erdmann E, Follath F, Krum H, Ponikowski P, Silke B, Van Veldhuisen DJ, Van De Ven L, Verkenne P, Lechat P; CIBIS-III investigators. Willenheimer R, et al. Among authors: lechat p. Eur J Heart Fail. 2004 Jun;6(4):493-500. doi: 10.1016/j.ejheart.2003.12.016. Eur J Heart Fail. 2004. PMID: 15182776 Free article. Clinical Trial.
Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril, as compared with the opposite sequence: results of the randomized Cardiac Insufficiency Bisoprolol Study (CIBIS) III.
Willenheimer R, van Veldhuisen DJ, Silke B, Erdmann E, Follath F, Krum H, Ponikowski P, Skene A, van de Ven L, Verkenne P, Lechat P; CIBIS III Investigators. Willenheimer R, et al. Among authors: lechat p. Circulation. 2005 Oct 18;112(16):2426-35. doi: 10.1161/CIRCULATIONAHA.105.582320. Epub 2005 Sep 4. Circulation. 2005. PMID: 16143696 Clinical Trial.
Effect on mode of death of heart failure treatment started with bisoprolol followed by Enalapril, compared to the opposite order: results of the randomized CIBIS III trial.
Krum H, van Veldhuisen DJ, Funck-Brentano C, Vanoli E, Silke B, Erdmann E, Follath F, Ponikowski P, Goulder M, Meyer W, Lechat P, Willenheimer R; behalf of the CIBIS III Investigators. Krum H, et al. Among authors: lechat p. Cardiovasc Ther. 2011 Apr;29(2):89-98. doi: 10.1111/j.1755-5922.2010.00185.x. Cardiovasc Ther. 2011. PMID: 20528880 Free article. Clinical Trial.
Evaluation of the functional status questionnaire in heart failure: a sub-study of the second cardiac insufficiency bisoprolol survival study (CIBIS-II).
Gallanagh S, Castagno D, Wilson B, Erdmann E, Zannad F, Remme WJ, Lopez-Sendon JL, Lechat P, Follath F, Höglund C, Mareev V, Sadowski Z, Seabra-Gomes RJ, Dargie HJ, McMurray JJ. Gallanagh S, et al. Among authors: lechat p. Cardiovasc Drugs Ther. 2011 Feb;25(1):77-85. doi: 10.1007/s10557-011-6284-x. Cardiovasc Drugs Ther. 2011. PMID: 21287410 Free article. Clinical Trial.
Expert consensus document on beta-adrenergic receptor blockers.
López-Sendón J, Swedberg K, McMurray J, Tamargo J, Maggioni AP, Dargie H, Tendera M, Waagstein F, Kjekshus J, Lechat P, Torp-Pedersen C; Task ForceOn Beta-Blockers of the European Society of Cardiology. López-Sendón J, et al. Among authors: lechat p. Eur Heart J. 2004 Aug;25(15):1341-62. doi: 10.1016/j.ehj.2004.06.002. Eur Heart J. 2004. PMID: 15288162 Review. No abstract available.
Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease. The Task Force on ACE-inhibitors of the European Society of Cardiology.
López-Sendón J, Swedberg K, McMurray J, Tamargo J, Maggioni AP, Dargie H, Tendera M, Waagstein F, Kjekshus J, Lechat P, Torp-Pedersen C; Task Force on ACE-inhibitors of the European Society of Cardiology. López-Sendón J, et al. Among authors: lechat p. Eur Heart J. 2004 Aug;25(16):1454-70. doi: 10.1016/j.ehj.2004.06.003. Eur Heart J. 2004. PMID: 15302105 Review. No abstract available.
Left bundle branch block as a risk factor for progression to heart failure.
Zannad F, Huvelle E, Dickstein K, van Veldhuisen DJ, Stellbrink C, Køber L, Cazeau S, Ritter P, Maggioni AP, Ferrari R, Lechat P. Zannad F, et al. Among authors: lechat p. Eur J Heart Fail. 2007 Jan;9(1):7-14. doi: 10.1016/j.ejheart.2006.04.011. Epub 2006 Aug 4. Eur J Heart Fail. 2007. PMID: 16890486 Free article. Review.
616 results